A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

Completed · Phase 2

Conditions studied: HIV Infection

In brief

This is a 48-week study to collect additional information on the safety, tolerability, pharmacokinetics, and antiviral activity of an investigational regimen (course of therapy) including FDA approved HIV drugs in HIV-infected patients 2 - 18 years old.

Key facts

Study ID

NCT00040664

Run by

ViiV Healthcare

People needed

69

Starts

2002-07-01

Expected to finish

2008-10-01

Last updated by the study team

2017-03-03

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — New Orleans, Louisiana, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Stony Brook, New York, United States
• GSK Investigational Site — The Bronx, New York, United States
• GSK Investigational Site — Chapel Hill, North Carolina, United States
• GSK Investigational Site — Durham, North Carolina, United States
• GSK Investigational Site — Cleveland, Ohio, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Fort Worth, Texas, United States
• GSK Investigational Site — Richmond, Virginia, United States
• GSK Investigational Site — Toronto, Ontario, Canada
• GSK Investigational Site — Montreal, Quebec, Canada
• GSK Investigational Site — Modena, Emilia-Romagna, Italy
• GSK Investigational Site — Rome, Lazio, Italy
• GSK Investigational Site — Genoa, Liguria, Italy
• GSK Investigational Site — Milan, Lombardy, Italy
• GSK Investigational Site — Milan, Lombardy, Italy
• GSK Investigational Site — Pavia, Lombardy, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.